# Richard N. Fedorak

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/richard-n-fedorak/

## Facts

| Field | Value |
| --- | --- |
| Citations | 38,553 |
| Field | Inflammatory Bowel Disease |
| h-index | 85 |
| i10-index | 285 |
| OpenAlex ID | https://openalex.org/A5021559660 |
| ORCID iD | https://orcid.org/0000-0002-7382-0080 |
| Works | 604 |

## Researcher papers

- [The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic Hemostasis and Proton Pump Inhibition are Associated with Improved Outcomes in a Real-Life Setting](https://scholariq.org/papers/the-canadian-registry-on-nonvariceal-upper-gastrointestinal-bleeding-and/)
- [Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection](https://scholariq.org/papers/infliximab-reduces-endoscopic-but-not-clinical-recurrence-of-crohn-s-disease/)
- [Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD](https://scholariq.org/papers/oral-versus-intravenous-iron-replacement-therapy-distinctly-alters-the-gut/)
- [Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin](https://scholariq.org/papers/treatment-of-active-crohn-s-disease-with-mln0002-a-humanized-antibody-to-the-4-7/)
- [No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease](https://scholariq.org/papers/no-difference-between-latiglutenase-and-placebo-in-reducing-villous-atrophy-or/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Gut microbiota and health](https://scholariq.org/topics/gut-microbiota-and-health/)
- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.